Edesa Biotech, Inc.
NASDAQ:EDSABiotechnology
+$0.09 today
- Market cap
- $55.39M
- Beta
- 1.07
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$1.27
Volume 0.07M
Average 0.62M
EDSA EBITDA Margin
EBITDA as a percentage of revenue.
Edesa Biotech, Inc.NASDAQ: EDSA
EBITDA Margin · Q2 FY2026 · quarter ended Mar 2026
EBITDA Margin not reported for Q2 FY2026
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA Margin history
Percent of revenue · from the income statement
No EBITDA Margin data reported for this period type.
EBITDA Margin vs competitors
How EDSA compares with its peers on the latest reported figures
No competitor EBITDA Margin figures are available to compare.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 118.79K | 118.19K | 183.47K | 186.05K | 119.27K |
| Gross Profit | (118.79K) | (118.19K) | (183.47K) | (186.05K) | (119.27K) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 17.95M | 13.34M | 4.79M | 2.88M | 3.67M |
| Selling, General & Admin | 5.73M | 5.04M | 4.43M | 4.13M | 4.24M |
| Operating Expenses | 23.68M | 18.37M | 9.22M | 7.01M | 7.79M |
| Depreciation & Amortization | 118.79K | 118.19K | 183.47K | 186.05K | 119.27K |
| EBITDA | (13.22M) | (17.43M) | (8.19M) | (5.98M) | (7.07M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (23.68M) | (18.37M) | (9.22M) | (7.01M) | (7.91M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 11.17K | 64 | 289.85K | 153.5K | 2.56K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 10.34M | 822.67K | 849.14K | 845.5K | 726.84K |
| Income Before Tax | (13.34M) | (17.55M) | (8.37M) | (6.17M) | (7.18M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 800 | 800 | 800 | 800 | 800 |
| Net Income | (13.34M) | (17.55M) | (8.37M) | (6.17M) | (7.19M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (7.74) | (8.37) | (2.93) | (1.93) | (1.27) |
| EPS (Diluted) | (7.73) | (8.37) | (2.93) | (1.93) | (1.27) |
| Weighted Avg Shares | 1.73M | 2.1M | 2.86M | 3.2M | 5.68M |
| Weighted Avg Shares (Diluted) | 1.73M | 2.1M | 2.86M | 3.2M | 5.68M |
Edesa Biotech, Inc.
NASDAQ:EDSA
Intrinsic Alpha fair value
Locked
Current Price
$5.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.